About Celmatix
Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Celmatix’s proprietary multi-omic ovarian health platform, the world’s largest of its kind, is the foundation of the company’s novel pipeline of first-in-class therapies. For more information visit www.celmatix.com.
|
|
|
11-50 employees
View all Celmatix employees
|
|
Biotechnology Research
|
|
14 Wall Street, New York, NY 10005, US
|
|
2009
|
|
Women's Health, Biotech, Bioinformatics, Genomics, Drug Development, Reproductive Biology And Medicine
|
Celmatix Alternatives
Frequently Asked Questions about Celmatix
The decision makers in Celmatix are Caterina Clementi, Charlotte Frank Sage, David Sable, etc. Click to Find Celmatix decision makers emails.
Celmatix Staff Directory
Search Celmatix Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
